According to the Complainant, the Novartis group is a pharmaceutical and healthcare group, which provides solutions to address the evolving needs of patients, by developing and delivering innovative medical treatments and drugs. The Complainant’s products are manufactured and sold in many countries worldwide, including Russia.<\/p>\n
The Complainant is the owner of a large domain name portfolio, which includes domain names with the wording NOVARTIS, such as <novartis.com>, registered since 1996, or <novartispharama.com>, registered since 1999.<\/p>\n
The disputed domain name <novartis-check.com> was registered on October 31, 2022.<\/p>", "other_legal_proceedings": "
The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "
The Complainant submits that the requirements of the Policy have been met and that the disputed domain name should be transferred to it.
No administratively compliant Response has been filed. <\/p>",
"rights": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "
The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "
The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "
The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>", "decision": "Accepted", "panelists": [ "Tom Heremans" ], "date_of_panel_decision": "2023-02-02 00:00:00", "informal_english_translation": "
The Complainant is the owner of the trademark NOVARTIS which is registered as a word mark for a.o. pharmaceutical products in numerous countries all over the world, such as:<\/p>\n
- International word mark NOVARTIS, registered on June 29, 2020, under number 1544148;
- International word mark NOVARTIS, registered on July 1, 1996, under number 663765;
- Russian combined mark NOVARTIS, registered on August 6, 2013, under number 526567.<\/p>",
"decision_domains": {
"novartis-check.com ": "TRANSFERRED"
},
"panelist": null,
"panellists_text": null
}